CTLA-4 deficiency in FoxP3+ cells impairs the inhibitory functions of Treg cells which are considered the biggest obstacle in immunotherapy targets due to their anti-tumor suppressing nature [30]. This evidence concerns the gene CTLA4 and neoplasm.